Page last updated: 2024-10-31

mianserin and Leukemia P388

mianserin has been researched along with Leukemia P388 in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaffrézou, JP1
Chen, KG1
Durán, GE1
Muller, C1
Bordier, C1
Laurent, G1
Sikic, BI1
Levade, T1

Other Studies

1 other study available for mianserin and Leukemia P388

ArticleYear
Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.
    Biochimica et biophysica acta, 1995, 04-06, Volume: 1266, Issue:1

    Topics: Affinity Labels; Animals; Desipramine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; In

1995